Fractyl Health Inc.
Clinical trials sponsored by Fractyl Health Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New procedure aims to keep weight off after GLP-1 drugs are stopped Results expected Feb 2027 (estimated)
-
New procedure aims to keep weight off after GLP-1 drugs are stopped
Disease control OngoingThis study tests a procedure called Revita DMR, which uses a thin tube to treat the lining of the upper gut, to help people with obesity keep weight off after they stop taking the weight-loss drug tirzepatide. About 315 participants who lost at least 15% of their body weight on t…
Sponsor: Fractyl Health Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could a gut procedure help control diabetes? new trial investigates
Disease control PausedThis study tests a procedure called duodenal mucosal resurfacing (DMR) using the Revita system in people with type 2 diabetes whose blood sugar is not well controlled with medication. About 320 adults will be randomly assigned to receive either the real procedure or a sham (fake)…
Sponsor: Fractyl Health Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC